taurine has been researched along with Adenocarcinoma in 33 studies
Adenocarcinoma: A malignant epithelial tumor with a glandular organization.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of this prospective study was to observe the influence of long-term intravenous taurolidine on the development of lung metastases after intravenous injection of colon adenocarcinoma cells." | 3.75 | Taurolidine in the prevention and therapy of lung metastases. ( Beshay, M; Bilici, M; Gazdhar, A; Gugger, M; Hoksch, B; Rufer, B; Schmid, RA, 2009) |
| "0% taurolidine on the invasion of 1 x 10(5) CC531 adenocarcinoma cells." | 3.73 | Impact of taurolidine on the growth of CC531 coloncarcinoma cells in vitro and in a laparoscopic animal model in rats. ( Krüger, S; Lippert, H; Nestler, G; Pross, M; Schubert, D; Schulz, HU, 2005) |
| "VEGF and TNFalpha levels of rat colon adenocarcinoma cells (DHD/K12/TRb) were analyzed in the supernatant undergoing treatment of increasing taurolidine doses in vitro." | 3.73 | Effects of increasing doses of a bolus injection and an intravenous long-term therapy of taurolidine on subcutaneous (metastatic) tumor growth in rats. ( Braumann, C; Jacobi, CA; Kilian, M; Menenakos, C; Schoenbeck, M, 2005) |
| "The effect of taurolidine, heparin, and povidone-iodine on the growth of colon adenocarcinoma DHD/K12/TRb was measured in rats undergoing laparoscopy with carbon dioxide (n = 40), helium (n = 40), or xenon (n = 40)." | 3.70 | Influence of different gases and intraperitoneal instillation of antiadherent or cytotoxic agents on peritoneal tumor cell growth and implantation with laparoscopic surgery in a rat model. ( Jacobi, CA; Müller, JM; Volk, T; Wildbrett, P, 1999) |
| "The effects of taurolidine, heparin, and povidone iodine on the growth of rat and human colon adenocarcinoma as well as gallbladder carcinoma were investigated in vitro." | 3.70 | New therapeutic strategies to avoid intra- and extraperitoneal metastases during laparoscopy: results of a tumor model in the rat. ( Jacobi, CA; Müller, JM; Ordemann, J; Peter, FJ; Wenger, FA, 1999) |
| "After subcutaneous and intraperitoneal injection of 10(4) cells of colon adenocarcinoma (DHD/K12/TRb) the influences of either taurolidine or taurolidine/heparin on intraperitoneal and subcutaneous tumour growth were investigated in 105 rats undergoing laparoscopy with carbon dioxide." | 3.70 | Influence of intraperitoneal and systemic application of taurolidine and taurolidine/heparin during laparoscopy on intraperitoneal and subcutaneous tumour growth in rats. ( Braumann, C; Jacobi, CA; Ordemann, J; Wildbrett, P, 2000) |
| "The effect of taurolidine and heparin on growth of colon adenocarcinoma DHD/K12/TRb was measured in vitro and in vivo." | 3.69 | Inhibition of peritoneal tumor cell growth and implantation in laparoscopic surgery in a rat model. ( Böhm, B; Jacobi, CA; Müller, JM; Ordemann, J; Sabat, R; Zieren, HU, 1997) |
| "In order to prevent tumor metastases, the effect of taurolidine and heparin on the growth of colon adenocarcinoma DHD/K12/TRb was measured in vitro and in a rat model." | 3.69 | [Peritoneal instillation of taurolidine and heparin for preventing intraperitoneal tumor growth and trocar metastases in laparoscopic operations in the rat model]. ( Jacobi, CA; Müller, JM; Ordemann, J; Sabat, R; Volk, HD; Wenger, F, 1997) |
| "We have studied the influence of the peripheral vasodilator hydralazine (HDZ) on the vasculature and blood perfusion of two members of a series of subcutaneous murine adenocarcinomata of the colon (MAC tumours), and the influence of HDZ on the efficacy and/or toxicity of TCNU and melphalan." | 3.68 | The influence of hydralazine on the vasculature, blood perfusion and chemosensitivity of MAC tumours. ( Bibby, MC; Cox, JA; Crawford, SM; Quinn, PK, 1992) |
| "330 mg) of intraperitoneal metastases in comparison to the control group (p = 0." | 1.34 | Instillation of taurolidine/heparin after laparotomy reduces intraperitoneal tumour growth in a colon cancer rat model. ( Braumann, C; Jacobi, CA; Mueller, JM; Opitz, I; Van der Veen, H; Witte, N, 2007) |
| "Furthermore the number of liver metastasis per animal was reduced after lavage with taurolidin (2 +/- 2) and Octreotide (2." | 1.33 | Impact of taurolidin and octreotide on liver metastasis and lipid peroxidation after laparoscopy in chemical induced ductal pancreatic cancer. ( Braumann, C; Gregor, JI; Guski, H; Heukamp, I; Jacobi, CA; Kilian, M; Schimke, I; Walz, MK; Wenger, FA, 2005) |
| "Taurolidine has been successfully used as a disinfectant and to prevent the spreading and growth of tumor cells after surgical excision." | 1.32 | The tumor-suppressive reagent taurolidine is an inhibitor of protein biosynthesis. ( Braumann, C; Dubiel, W; Henke, W; Jacobi, CA, 2004) |
| "Human pancreatic cancer cells (Capan-1 cell line) were heterotransplanted subcutaneously into nude mice." | 1.29 | Combined magnetic resonance imaging and spectrometry for characterization of human pancreatic adenocarcinoma (Capan-1) heterotransplanted in nude mice. ( Chemin-Thomas, C; Esclassan, J; Hollande, E; Palévody, C, 1994) |
| " The results show that the route of administration influences plasma concentrations, bioavailability and tissue and tumour concentrations." | 1.27 | Effects of routes of administration of TCNU on its plasma, tissue and tumour concentrations. ( Bibby, MC; Bloomer, JC; Double, JA; Loadman, PM, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (18.18) | 18.7374 |
| 1990's | 11 (33.33) | 18.2507 |
| 2000's | 14 (42.42) | 29.6817 |
| 2010's | 2 (6.06) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Holm, JB | 1 |
| Grygorczyk, R | 1 |
| Lambert, IH | 1 |
| Hoksch, B | 1 |
| Rufer, B | 1 |
| Gazdhar, A | 1 |
| Bilici, M | 1 |
| Beshay, M | 1 |
| Gugger, M | 1 |
| Schmid, RA | 1 |
| Chatzakos, V | 1 |
| Slätis, K | 1 |
| Djureinovic, T | 1 |
| Helleday, T | 1 |
| Hunt, MC | 1 |
| Opitz, I | 3 |
| van der Veen, HC | 1 |
| Braumann, C | 9 |
| Ablassmaier, B | 1 |
| Führer, K | 1 |
| Jacobi, CA | 13 |
| Wittich, P | 1 |
| Mearadji, A | 1 |
| Marquet, RL | 1 |
| Bonjer, HJ | 1 |
| Henke, W | 1 |
| Dubiel, W | 1 |
| Kilian, M | 2 |
| Gregor, JI | 1 |
| Heukamp, I | 1 |
| Guski, H | 1 |
| Schimke, I | 1 |
| Walz, MK | 1 |
| Wenger, FA | 2 |
| Nestler, G | 1 |
| Schulz, HU | 1 |
| Schubert, D | 1 |
| Krüger, S | 1 |
| Lippert, H | 1 |
| Pross, M | 1 |
| Stuhldreier, B | 1 |
| Bobrich, E | 2 |
| Menenakos, C | 4 |
| Rogalla, S | 1 |
| Schoenbeck, M | 1 |
| Cantin, AM | 1 |
| Bilodeau, G | 1 |
| Ouellet, C | 1 |
| Liao, J | 1 |
| Hanrahan, JW | 1 |
| Kristiansen, G | 1 |
| Van der Veen, H | 1 |
| Witte, N | 1 |
| Mueller, JM | 1 |
| Atanassov, V | 1 |
| Pfirrmann, RW | 1 |
| Guenther, N | 1 |
| Teder, H | 1 |
| Johansson, CJ | 1 |
| d'Argy, R | 1 |
| Lundin, N | 1 |
| Gunnarsson, PO | 1 |
| Chemin-Thomas, C | 1 |
| Palévody, C | 1 |
| Esclassan, J | 1 |
| Hollande, E | 1 |
| Ordemann, J | 4 |
| Böhm, B | 1 |
| Zieren, HU | 1 |
| Sabat, R | 2 |
| Müller, JM | 4 |
| Wenger, F | 1 |
| Volk, HD | 1 |
| Suzuki, H | 1 |
| Seto, K | 1 |
| Mori, M | 1 |
| Suzuki, M | 1 |
| Miura, S | 1 |
| Ishii, H | 1 |
| Wildbrett, P | 2 |
| Volk, T | 1 |
| Peter, FJ | 1 |
| McCourt, M | 1 |
| Wang, JH | 1 |
| Sookhai, S | 1 |
| Redmond, HP | 1 |
| Quinn, PK | 1 |
| Bibby, MC | 4 |
| Cox, JA | 1 |
| Crawford, SM | 1 |
| Loadman, PM | 2 |
| al-Ghabban, AF | 1 |
| Double, JA | 3 |
| Bach, F | 3 |
| Vibe-Petersen, J | 3 |
| Sørensen, JB | 2 |
| Dombernowsky, P | 3 |
| Hansen, HH | 3 |
| Pedersen, AG | 1 |
| Smyth, J | 1 |
| Atassi, G | 1 |
| Dumont, P | 1 |
| Gosse, C | 1 |
| Fournier, JP | 1 |
| Gouyette, A | 1 |
| Roger, P | 1 |
| Gundersen, S | 1 |
| Cavalli, F | 1 |
| Bruntsch, U | 1 |
| Renard, J | 1 |
| Van Glabbeke, M | 1 |
| Pinedo, H | 1 |
| Bloomer, JC | 1 |
| Morris, CM | 1 |
| Heaf, JG | 1 |
| Hansen, M | 1 |
33 other studies available for taurine and Adenocarcinoma
| Article | Year |
|---|---|
Volume-sensitive release of organic osmolytes in the human lung epithelial cell line A549: role of the 5-lipoxygenase.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Adenocarcinoma; Adenosine Triphosphate; Amino Acid | 2013 |
Taurolidine in the prevention and therapy of lung metastases.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Line, Tumor; Colonic Neoplasms; Lung Neoplasms; | 2009 |
N-acyl taurines are anti-proliferative in prostate cancer cells.
Topics: Adenocarcinoma; Apoptosis; Arachidonic Acids; Cannabinoid Receptor Modulators; Cell Count; Cell Cycl | 2012 |
The influence of adhesion prophylactic substances and taurolidine/heparin on local recurrence and intraperitoneal tumor growth after laparoscopic-assisted bowel resection of colon carcinoma in a rat model.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cellulose, Oxidized; Colonic Neoplasms; Disease Mode | 2003 |
Irrigation of port sites: prevention of port site metastases?
Topics: Adenocarcinoma; Animals; Heparin; Laparoscopy; Male; Neoplasm Seeding; Neoplasm Transplantation; Pne | 2004 |
The tumor-suppressive reagent taurolidine is an inhibitor of protein biosynthesis.
Topics: Adenocarcinoma; Antineoplastic Agents; Bacteria; Colonic Neoplasms; Dose-Response Relationship, Drug | 2004 |
Impact of taurolidin and octreotide on liver metastasis and lipid peroxidation after laparoscopy in chemical induced ductal pancreatic cancer.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma, Pancreatic Ductal; Cricetinae; Laparoscop | 2005 |
Impact of taurolidine on the growth of CC531 coloncarcinoma cells in vitro and in a laparoscopic animal model in rats.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Adhesion; Cell Line, Tumor; Colonic Neoplasms; | 2005 |
High doses of taurolidine inhibit advanced intraperitoneal tumor growth in rats.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Biopsy; Cell Division; Cell Line, Tumor; Chemical an | 2005 |
Effects of increasing doses of a bolus injection and an intravenous long-term therapy of taurolidine on subcutaneous (metastatic) tumor growth in rats.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Body Weight; Cell Line, Tumor; Colonic Neoplasms; In | 2005 |
Oxidant stress suppresses CFTR expression.
Topics: Adenocarcinoma; Antioxidants; Cell Line, Tumor; Colonic Neoplasms; Cyclic AMP; Cystic Fibrosis Trans | 2006 |
Influence of intraperitoneal application of taurolidine/heparin on expression of adhesion molecules and colon cancer in rats undergoing laparoscopy.
Topics: Adenocarcinoma; Animals; Anticoagulants; Antineoplastic Agents; Cadherins; Cell Adhesion Molecules; | 2007 |
Instillation of taurolidine/heparin after laparotomy reduces intraperitoneal tumour growth in a colon cancer rat model.
Topics: Abdominal Neoplasms; Adenocarcinoma; Animals; Anticoagulants; Antineoplastic Agents; Colonic Neoplas | 2007 |
Leukopoiesis is not affected after intravenous treatment with the novel antineoplastic agent taurolidine. Results of an experimental study in rats.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Line, Tumor; Colonic Neoplasms; Leukopoiesis; M | 2008 |
The effect of different dose levels of degradable starch microspheres (Spherex) on the distribution of a cytotoxic drug after regional administration to tumour-bearing rats.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carbon Radioisotopes; Colonic Neoplasms; Injections, | 1995 |
Combined magnetic resonance imaging and spectrometry for characterization of human pancreatic adenocarcinoma (Capan-1) heterotransplanted in nude mice.
Topics: Adenocarcinoma; Animals; Fatty Acids, Unsaturated; Glycerylphosphorylcholine; Humans; Magnetic Reson | 1994 |
Inhibition of peritoneal tumor cell growth and implantation in laparoscopic surgery in a rat model.
Topics: Adenocarcinoma; Animals; Cell Division; Colonic Neoplasms; Disease Models, Animal; Drug Combinations | 1997 |
[Peritoneal instillation of taurolidine and heparin for preventing intraperitoneal tumor growth and trocar metastases in laparoscopic operations in the rat model].
Topics: Adenocarcinoma; Animals; Anti-Infective Agents, Local; Cell Division; Colonic Neoplasms; Dose-Respon | 1997 |
Monochloramine induced DNA fragmentation in gastric cell line MKN45.
Topics: Adenocarcinoma; Ammonia; Chloramines; DNA Fragmentation; Gastric Mucosa; Helicobacter pylori; Humans | 1998 |
Influence of different gases and intraperitoneal instillation of antiadherent or cytotoxic agents on peritoneal tumor cell growth and implantation with laparoscopic surgery in a rat model.
Topics: Adenocarcinoma; Animals; Anti-Infective Agents; Anticoagulants; Carbon Dioxide; Colonic Neoplasms; H | 1999 |
New therapeutic strategies to avoid intra- and extraperitoneal metastases during laparoscopy: results of a tumor model in the rat.
Topics: Adenocarcinoma; Animals; Anti-Infective Agents, Local; Carbon Dioxide; Colonic Neoplasms; Gallbladde | 1999 |
Taurolidine inhibits tumor cell growth in vitro and in vivo.
Topics: Adenocarcinoma; Animals; Anti-Infective Agents, Local; Cell Death; Cell Division; Cell Survival; Col | 2000 |
Influence of intraperitoneal and systemic application of taurolidine and taurolidine/heparin during laparoscopy on intraperitoneal and subcutaneous tumour growth in rats.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Drug Synergi | 2000 |
The influence of hydralazine on the vasculature, blood perfusion and chemosensitivity of MAC tumours.
Topics: Adenocarcinoma; Animals; Bone Marrow; Cell Division; Cell Line; Colonic Neoplasms; Hydralazine; Male | 1992 |
Influence of hydralazine on the pharmacokinetics of tauromustine (TCNU) in mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Chromatography, High Pressure Liquid; Dose-Response | 1992 |
Phase II trial of TCNU and vindesine in patients with adenocarcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female | 1990 |
TCNU in adenocarcinoma of the lung: a phase II study with divided doses.
Topics: Adenocarcinoma; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Nitrosourea Compounds; Taurin | 1990 |
A phase II trial of TCNU in patients with squamous, adeno and large cell carcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Small Cell; Carcinoma, Squamous Cell; | 1989 |
Characterization of the anti-tumour activity against solid tumours of a new nitrosoureido sugar: Cy 233.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carmustine; Colonic Neoplasms; Dose-Response Relatio | 1989 |
TCNU (LS 2667), a new active drug in the treatment of advanced colorectal cancer. EORTC Early Clinical Trials Group.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Colorectal Neoplasms; Drug Evaluation; Humans; M | 1989 |
Effects of routes of administration of TCNU on its plasma, tissue and tumour concentrations.
Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Agents; Biological Availability; Colon | 1988 |
Anti-tumour activity of TCNU in a panel of transplantable murine colon tumours.
Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Agents; Colonic Neoplasms; Dose-Respon | 1988 |
Treatment of refractory cancer-associated hypercalcemia with aminohydroxypropylidene diphosphonate.
Topics: Adenocarcinoma; Antineoplastic Agents; Diphosphonates; Female; Humans; Hypercalcemia; Lung Neoplasms | 1988 |